Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Ostex International

Executive Summary

Ostex International: Robert Glaser joins company as president and chief operating officer. Glaser most recently was with Merck as senior VP-marketing, where he was responsible for all osteoporosis-related products. Seattle-based Ostex discovers and develops diagnostics and therapeutics for skeletal diseases and has agreements with companies including Merck, Wyeth-Ayerst, J&J, Corning Clinical Labs and SmithKline Beecham. Glaser will be replaced at Merck by VP-Marketing Jeremy Allen, who has been with the company since August. Allen also is president of the Merck-affiliated Bone Measurement Institute...
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027991

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel